Fig. 2From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisa \(CI_{AE}(t)\) estimated through the AJ formula; b \(AN_{AE}(t)\) and \(KM_{AE}(t)\) step curves of the cumulative \(CSH_{AE}(t)\) and of the cumulative incidence of AE, respectivelyBack to article page